Real-world efficacy and safety of brolucizumab

被引:0
|
作者
Walter, Scott [1 ,2 ]
Saba, Nicholas [2 ,3 ]
机构
[1] Retina Consultants PC, Hartford, CT USA
[2] Univ Connecticut, Sch Med, Surg, Farmington, CT USA
[3] Eastern Connecticut Hlth Network, Med, Manchester, CT USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
456
引用
收藏
页数:3
相关论文
共 50 条
  • [41] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Shuntaro Obi
    Takahisa Sato
    Shinpei Sato
    Miho Kanda
    Yuta Tokudome
    Yuichiro Kojima
    Yoji Suzuki
    Kenji Hosoda
    Toshihiro Kawai
    Yuji Kondo
    Yoshihiro Isomura
    Hiroshi Ohyama
    Keiko Nakagomi
    Hiroshi Ashizawa
    Yuko Miura
    Hiroyuki Amano
    Hitoshi Mochizuki
    Masao Omata
    Hepatology International, 2019, 13 : 199 - 204
  • [42] SAFETY AND EFFICACY OUTCOMES ASSOCIATED WITH REAL-WORLD USE OF ANGIOTENSIN II
    Jennings, Mckenna
    Czosnowski, Quinn
    Kruer, Rachel
    Pollander, Abby
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 422 - 422
  • [43] Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
    Weiwen Gao
    Jian Yang
    Xiangwang Zhang
    Lei Tian
    Dong Xu
    Shuyun Xu
    Dong Liu
    Yan He
    Infectious Diseases and Therapy, 2024, 13 (12) : 2509 - 2526
  • [44] REAL-WORLD DATA ON THE EFFICACY AND SAFETY OF IXEKIZUMAB IN PATIENTS WITH PLAQUE PSORIASIS
    Stefanaki, Irene
    Rompoti, Natalia
    Panagakis, Pantelis
    Papoutsaki, Marina
    Politou, Maria
    Vavouli, Charitomeni
    Mpefon, Aggeliki
    Fiori, Kousta
    Eleni, Lazou
    Zaimi, Maria
    Koumprentziotis, Ioannis-Alexios
    Zafeiropoulou, Theodora
    Chasapi, Vasiliki
    Stratigos, Alexander
    Nicolaidou, Electra
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [45] Efficacy and safety of dapagliflozin in children with kidney disease: real-world data
    Choi, Naye
    Kim, Ji Hyun
    Park, Peong Gang
    Lee, Hyeonju
    Min, Jeesu
    Park, Hye Won
    Ahn, Yo Han
    Kang, Hee Gyung
    PEDIATRIC NEPHROLOGY, 2024, : 3551 - 3558
  • [46] Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC
    Wang, Kaiwen
    Du, Robyn
    Myall, Nathaniel J.
    Lewis, Whitney E.
    Uy, Natalie
    Hong, Lingzhi
    Skoulidis, Ferdinandos
    Byers, Lauren A.
    Tsao, Anne
    Cascone, Tina
    Pozadzides, Jenny
    Tu, Janet
    Negrao, Marcelo, V
    Gibbons, Don L.
    Park, Keunchil
    Rinsurongkawong, Waree
    Lee, J. Jack
    Gandara, David
    Behl, Deepti
    Shu, Catherine A.
    Riess, Jonathan W.
    Baik, Christina
    Wakelee, Heather A.
    Vaporciyan, Ara A.
    Heymach, John, V
    Zhang, Jianjun
    Le, Xiuning
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (03) : 500 - 506
  • [47] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [48] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Zarbin, Marco A.
    MacCumber, Mathew W.
    Karcher, Helene
    Adiguzel, Eser
    Mayhook, Andrew
    LaPrise, Andrew
    Bilano, Ver L.
    Igwe, Franklin
    Ip, Michael S.
    Wykoff, Charles C.
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (05) : 1357 - 1368
  • [49] Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
    Marco A. Zarbin
    Mathew W. MacCumber
    Helene Karcher
    Eser Adiguzel
    Andrew Mayhook
    Andrew LaPrise
    Ver L. Bilano
    Franklin Igwe
    Michael S. Ip
    Charles C. Wykoff
    Ophthalmology and Therapy, 2024, 13 : 1357 - 1368
  • [50] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    FRONTIERS IN PHARMACOLOGY, 2023, 14